Table 5.
Summary of studies with relatively large cohort of patients who underwent hepatectomy for liver metastases from gastrointestinal primaries other than gastric cancer and gastrointestinal stromal tumors
| Disease | Ref. | Year | Period | No. of patients | MST (mo) | 3-ysr (%) | 5-ysr (%) | Factors associated with worse overall survival |
| Peri-ampullary | De Jong et al[34] | 2010 | 1993-2009 | 40 | 17 [23 (intestinal), 13 (pancreaticobiliary)] | 18 | NR | Intestinal type (ampullary or duodenal) tumors |
| Ampullary | Adam et al[10]1 | 2006 | 1983-2004 | 15 | 38 | NR | 46 | NR |
| Small bowel | Adam et al[10]1 | 2006 | 1983-2004 | 28 | 58 | NR | 49 | NR |
| Pancreas | Adam et al[10]1 | 2006 | 1983-2004 | 40 | 20 | NR | 25 | NR |
| Schiergens et al[16]1 | 2016 | 2003-2013 | 19 | 7 | 17 | NR | NR | |
| Esophagous | Adam et al[10]1 | 2006 | 1983-2004 | 20 | 16 | 32 | NR | NR |
| Ichida et al[35] | 2013 | 2003-2005 | 5 | 13 | NR | NR | NR |
1
As a part of the report of on-colorectal non-neuroendocrine liver metastases. MST: Median survival time; ysr: Year survival rate; NR: Not reported.